Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Frozen Shoulder

Not Applicable

Completed

• Conditions: Pain, Shoulder
• Interventions: Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine

• Registration Number: NCT05037994
• Lead Sponsor: Zagazig University

Brief Summary

The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes:

Control Group (C Group) : Patients receive continuous US suprascapular nerve block only.

Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

Both groups compared as regard:

Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-01
• Primary Completion: 2021-09-01
• Study First Submitted: 2021-09-03
• Study First Submitted QC: 2021-09-03
• Study First Posted: 2021-09-08
• Study Completion: 2021-10-30
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-14
• Last Update Posted: 2021-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Body mass index ≥ 18 Kg/m2 ≤ 30Kg/m2
• ASA I, II or III.
• Cooperative patients.

Exclusion Criteria

• local infection at site of injection.
• coagulopathy
• previous history of mental disorders or chronic drug abuse (opioids, tranquilizers)
• known hypersensitivity to any of the drugs used in the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Gabapentin Group (G Group)	Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine	Patients will receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.
Control Group (C Group)	Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine	Patients will receive continuous US suprascapular nerve block only.

Primary Outcome Measures

Name	Time	Method
Visual analogue scale	6 weeks	10cm line where zero means no pain and ten means worse imaginary pain

Secondary Outcome Measures

Name	Time	Method
Range of passive and active movements	6 weeks	by goniometer
Patients satisfaction	6 weeks	by questionnaire with 3 degrees; 1. Fair; 2. Good; 3. Excellent

Trial Locations

Locations (1)

Amr Shaaban Elshafei; 🇪🇬 Zagazig, Egypt